TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Willingness to try
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Apnea/Hypopnea Index count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tolerance and acceptability of High Flow Nasal Cannula
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in Chronic Subclinical Neck or Upper Quadrant Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Anastomosis complication
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived Competence Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of Treatment/Services Utilization for Eating, Shape, or Weight Concerns
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in negative predictive value (NPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of 18F DOPA PET-CT for detection of brain metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of microanatomy as measured by WiSLO image reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of abnormal microanatomy as measured by WiSLO image reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of abnormal microanatomy from retinal photo imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of normalization of arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of reduction of systolic arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of reduction of diastolic arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of the adapted intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lipid metabolite production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline on the Unified Dyskinesia Rating Scale (UDysRS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMT of neutralizing antibodies against Delta variant on Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of neutralizing antibodies against Omicron variant on Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of neutralizing antibodies against Delta variant on Day 208
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of neutralizing antibodies against Omicron variant on Day 208
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Hyperemia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early survival following surgery of the proximal aorta
Endpoint domain: Mortality/survival
Primary endpoint: Late survival following surgery of the proximal aorta
Endpoint domain: Mortality/survival
Primary endpoint: Efficiency of penicillin allergy de-labelling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Level of Functional Capacity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lund Kennedy Endoscopy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women with positive ARNA Breast test confirmed by biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Positive Mental Health (WEMWBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUCt of CKD-348(5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-348(5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotoxicity effects of exposure to MNPLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean 24-hr systolic blood pressure (SBP) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in systolic blood pressure (SBP) from baseline to 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2-Year Event Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in neuropathic pain on DN4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pain intensity on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life on SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Interval Cortical Inhibition (SICI) Test-Retest Reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Task Related Up Modulation (TRUM) Test-Retest Reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Examination score of post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of participants with at least one Potentially inappropriate medications (PIMs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Potentially inappropriate medications (PIMs)
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluation of test of pelvic girdle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of pelvic girdle questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Development of dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of confirmed healed rotator cuff tear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of participants with suspected, probable, or confirmed TBD
Endpoint domain: Mortality/survival
Primary endpoint: Clinical outcome measured using established assessment tools and questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with CMV infection and reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Steady-state pharmacokinetics of DTG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: History of thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in horizontal clinical attachment level (HCAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlling biofilm formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All cause mortality rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Cardiovascular mortality rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Myocardial Infarction rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Reporting Adverse Events (AEs) or Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Dose-limiting Toxicities Incidence Count Among Study Participant
Endpoint domain: Adverse events/effects
Primary endpoint: 14 days mortality
Endpoint domain: Mortality/survival
Primary endpoint: duration of disease control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Social Appearance Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Eating Disorder-15
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Social Phobia Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Validity of samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from baseline body mass index (BMI) percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary non-perfusion zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Range of motion measurement using goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular best-corrected distance visual acuity (BCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance Rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adherence - Attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adherence - Self Reported
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adherence - Clinician Reported
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of tooth and tooth surfaces that became decayed or were treated for dental caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of enriched IFN-Υ+ T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Therapy dropout rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: serum amylase concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study follow-up rate and length
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Vaginal dryness severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain score on the numeric rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who regain pre-fracture mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Biomarkers and blast exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Biomarkers and neurophysiologic metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood Biomarkers and psychologic metrics
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adenoma detection yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cervical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in neck function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in proprioceptive inputs of cervical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perceived Stress Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Stress Coping Methods Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Brief Resilience Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quadruple Visual Analog Scale (QVAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CKD diagnosis rates
Endpoint domain: Mortality/survival
Primary endpoint: test of gross motor development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedsQol scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gugging Swallowing screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing quality of life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recurrence rate of pituitary adenoma
Endpoint domain: Mortality/survival
Primary endpoint: Elapsed Time to Complete Bilateral Ear Impressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serological status comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penile Curvature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune Overall Response Rate (iORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Kicking Velocity Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Run Speed Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agility Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Lu AG06466 and Lu AG06988
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal Fluid (CSF) Concentration of Lu AG06466 and Lu AG06988
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central MAGL Occupancy (%) Measured Using [18F]MNI-1188 PET Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF Concentrations of 2-arachidonolylglycerol (2-AG), 2-oleoylglycerol (2-OG), and arachidonic acid (AA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of neuroticism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blepharitis signs on slit-lamp examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability- Intervention Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dietary Intake: Number of Servings of Fruits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Physical Activity (Accelerometer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsessive-Compulsive Inventory-Revised (OCI-R) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsessional Beliefs Questionnaire (OBQ-20) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Depression Inventory -II (BDI-II) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Anxiety Inventory (BAI) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBsAg change from baseline to week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Accuracy of Uromonitor in diagnosis of bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VFQ-25 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: children's anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: children's fear scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Food intake assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in symptoms of premenstrual syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pain levels, including menstrual cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in mood stability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle Activation Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue Pressure Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of subjects achieving EASI 75 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Unassisted peak expiratory cough flow (PECF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in conflict in Adolescent Dating Relationship Inventory- Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parenting Stress Index - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Perceived Maternal Parenting Self-Efficacy Tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to complete 10 km trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive proprioceptive evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single Hop test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-leg landing task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Victorian Institute of Sport Assessment - Achilles questionnaire (VISA-A)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with abnormal vital signs, abnormal physical exam findings, abnormal ECG, and abnormal laboratory tests results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goal Attainment of IEP progress
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Attainment of Postsecondary Goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of participants with a minimum 1-point improvement in WSRS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of patients' skills development during the therapeutic educative programme
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Programme and environment (hosting) satisfaction questionnaire assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concussive symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional indicators
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fear measurement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with adverse events of special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline activity pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mesulam cancellation Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bisection Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glypican 3 as a predictive and diagnostic marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gut length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EEG Phase synchrony differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Days that Participants Use Digital Outpost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Clinical Assessments Completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Essential Tremor and dystonia quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with > 1.5°C rise of temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hepatic enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in complete blood count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adverse event and general acceptability
Endpoint domain: Adverse events/effects
Primary endpoint: Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Upper Extremity-Fugl Meyer (UE-FM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with PD
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with early PD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial stiffness - Pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of months spent in clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes